Antithrombotic Therapy in COVID-19 - A Scientific Position Statement by Heart Disease Management Program, National Health Mission, Government of Tamil Nadu
J Assoc Physicians India
.
2021 Jan;69(1):82-87.
Authors
Justin Paul Gnanaraj
1
,
Princy S Anne
2
,
Cecily Mary Majella
3
,
Prabhakar Durairaj
4
,
Ravichandran Edwin
5
,
Kumaresan Kannan
6
,
Veeramani Ramachandran
7
,
Nambirajan Jeyabalan
8
,
Nandakumaran Mohanan
9
,
Senthilraj Krishnan
10
,
Shanmugasundaram Somasundaram
11
Affiliations
1
Madras Medical College; National Health Mission, Tamil Nadu.
2
National Health Mission, Tamil Nadu; Tamil Nadu Government Multi Super Speciality Hospital.
3
Tamil Nadu Government Multi Super Speciality Hospital.
4
Apollo Hospitals Chennai, Tamil Nadu.
5
Government Tirunelveli Medical College.
6
Government Stanley Medical College.
7
Government Madurai Medical College.
8
Government Coimbatore Medical College.
9
Government Kilpauk Medical College.
10
National Health Mission, Tamil Nadu.
11
Billroth Hospitals, Chennai, Tamil Nadu.
PMID:
34227785
No abstract available
MeSH terms
COVID-19*
Disease Management
Fibrinolytic Agents*
Government
Humans
India
National Health Programs
SARS-CoV-2
Substances
Fibrinolytic Agents